Biotage AB Interim Report January -- September 2005
October 19, 2005 02:41 ET | Biotage AB
STOCKHOLM, Sweden, Oct. 19, 2005 (PRIMEZONE) -- Biotage AB: -- Sales in the third quarter 2005 amounted to 126.6 MSEK (84.5) and sales in the period January -- September 2005 to 292.0...
Skandia: Publication of Shareholder Information Document in Connection with Offer from Old Mutual
October 19, 2005 02:38 ET | Skandia
STOCKHOLM, Sweden, Oct. 19, 2005 (PRIMEZONE) -- On 23 September 2005, Skandia's Board of Directors announced that the Board was of the opinion that Old Mutual's offer was not attractive for Skandia's...
Aker Kvaerner deepwater contract for Gulf of Mexico
October 19, 2005 02:38 ET | Akastor ASA
The Blind Faith platform to be located in the Mississippi Canyon 650 block, approximately 162 miles southeast of New Orleans is part of the ultra-deepwater Gulf of Mexico in 6,500 feet water depth....
Dow Jones Indexes Logo
Dow Jones Indexes to Launch Dow Jones China Offshore 50 Index
October 19, 2005 02:30 ET | Dow Jones Indexes
NEW YORK, Oct. 19, 2005 (PRIMEZONE) -- Dow Jones Indexes, a leading global index provider, today announced the launch of the Dow Jones China Offshore 50 Index. The Dow Jones China Offshore 50 Index...
Telelogic
Telelogic Interim Report July -- September 2005
October 19, 2005 02:12 ET | Telelogic
MALMO, Sweden, Oct. 19, 2005 (PRIMEZONE) -- Telelogic: - 27% revenue growth - Pre-tax profit increased 14% - Strong growth in Americas and Germany - SEK 136.9 million in positive cash flow...
Crucell and DSM Announce PER.C6 Licensing Agreement with IQ Corporation for Production of Monoclonal Antibodies against Anthrax
October 19, 2005 02:12 ET | Crucell N.V.
LEIDEN and SITTARD, Netherlands, Oct. 19, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today...
Santhera Targets New
Santhera Targets New Indication with its Lead Compound
October 19, 2005 02:00 ET | Santhera Pharmaceuticals Holding AG
 ...
Invitation to press
Invitation to press conference:Amer Sports Corporation's interim report 1 January to 30 September 2005
October 19, 2005 01:43 ET | Amer Sports Oyj
You are invited to attend a press conference arranged to publish our interim results for the period 1 January to 30 September 2005. The press conference will be held on Wednesday 26th October 2005 at...
NOVARTIS logo.jpg
Study shows conversion to Myfortic® from current therapy significantly improved quality of life for kidney transplant patients
October 19, 2005 01:30 ET | Novartis Pharma AG
First-ever study in transplant patients utilized patient-reported measurement tools to differentiate between quality of life of existing therapies   Geneva, October 19, 2005 - Results of the...
Kutsu Vaisala Oyj:n
Kutsu Vaisala Oyj:n 9 kuukauden osavuosituloksen tiedotustilaisuuteen
October 19, 2005 00:40 ET | Vaisala Oyj
Kutsumme edustajanne tiedotustilaisuuteen, jossa toimitusjohtaja Pekka Ketonen esittelee Vaisala Oyj:n 9 kuukauden osavuosituloksen:   Aika:...
keyboard_arrow_left Previous Page
1...278062278063278064...286577
Next Page keyboard_arrow_right